| Serial Number | 98161571 |
| Word Mark | CONFLUENCE |
| Filing Date | Friday, September 1, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, November 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research in the field of pharmaceuticals and biotechnology; drug discovery services; drug discovery consulting services; medical and scientific research consulting services in the field of drug discovery and pharmaceutical drug development; providing medical and scientific research, namely, assay design and validation and biomarker assessment |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 27, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, August 3, 2017 |
| First Use In Commerce Date | Thursday, August 3, 2017 |
| Party Name | Aclaris Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Wayne, PA 19087 |
| Event Date | Event Description |
| Wednesday, September 27, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, November 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 30, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, September 5, 2023 | NEW APPLICATION ENTERED |
| Friday, May 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 3, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, May 3, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 30, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Tuesday, July 30, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Wednesday, July 31, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 30, 2024 | USE AMENDMENT FILED |
| Wednesday, July 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, August 25, 2024 | USE AMENDMENT ACCEPTED |
| Monday, August 26, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, August 26, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 12, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |